FDG-PET avidity as a prognostic biomarker for overall survival in renal cell carcinoma.

Abstract

e16564Background: Positron emission tomography with (18F)-fluorodeoxyglucose (FDG-PET) is not considered a standard of care (SOC) in renal cell carcinoma (RCC) because of its variability in metabol...